Toral Vaishnani
Toral Vaishnani has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aastha Aggarwal
Centre for Chronic Disease Control 5 Delhi
5 shared publications - Arvind Krishnamurthy
Surgical Oncology, Cancer Institute, Chennai, India
5 shared publications - Krithiga Shridhar
Centre for Chronic Conditions and Injuries, Public Health Foundation of India, Gurgaon, Haryana, India
5 shared publications - Rupak Shivakoti
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA
5 shared publications - Siddhartha Mandal
Centre for Chronic Disease Control, New Delhi, Delhi, India
5 shared publications - Spandan Chaudhary
Unigenome 4
5 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 3. Log Fold change (LFC) in differential abundance of established periodontal pathogens by tongue cancer cases (N = 31) and cancer-free controls (N = 31).
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 3. Log Fold change (LFC) in differential abundance of established periodontal pathogens by tongue cancer cases (N = 31) and cancer-free controls (N = 31).
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Data from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared with cancer-free controls. We conducted a case–control study in a tertiary care cancer hospital in Chennai, South India. Cases (N = 31) were those with newly diagnosed, pretreatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers, further classified as early-onset [diagnosed at 20–49 years (N = 12)] or late-onset cancers [diagnosed ≥50 years (N = 19)] for secondary exploratory analyses. Cancer-free controls (N = 31) were unrelated and frequency-matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analyses (n = 175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years, and a third were women. Although there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Furthermore, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, and Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiologic investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity. Prevention Relevance:This pilot study identified differences in overall microbiota and specific bacteria between cancer-free controls and tongue cancer cases in the oral cavity, specifically for early-onset cancers. The identified bacteria, including novel ones, can further be studied as salivary biomarkers for early-onset tongue cancers and to determine causality for prevention.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared with cancer-free controls. We conducted a case–control study in a tertiary care cancer hospital in Chennai, South India. Cases (N = 31) were those with newly diagnosed, pretreatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers, further classified as early-onset [diagnosed at 20–49 years (N = 12)] or late-onset cancers [diagnosed ≥50 years (N = 19)] for secondary exploratory analyses. Cancer-free controls (N = 31) were unrelated and frequency-matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analyses (n = 175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years, and a third were women. Although there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Furthermore, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, and Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiologic investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity. Prevention Relevance:This pilot study identified differences in overall microbiota and specific bacteria between cancer-free controls and tongue cancer cases in the oral cavity, specifically for early-onset cancers. The identified bacteria, including novel ones, can further be studied as salivary biomarkers for early-onset tongue cancers and to determine causality for prevention.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 1. Participants’ characteristics of early- and late-onset tongue cancer cases and cancer-free controls.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 1. Participants’ characteristics of early- and late-onset tongue cancer cases and cancer-free controls.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 2. Unadjusted and adjusted β-coefficient estimates with 95% confidence intervals (CI) of α-diversity by case control.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Oral Microbiota in Early- and Late-Onset Tongue Cancers: A Pilot Case–Control Study
Supplemental Table 2. Unadjusted and adjusted β-coefficient estimates with 95% confidence intervals (CI) of α-diversity by case control.
- 6 May 2026
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (8) , 443-451
Oral microbiota in early- and late-onset tongue cancers: A pilot case-control study
Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared to cancer-free controls. We conducted a case-control study in a tertiary care cancer hospital in Chennai, South India. Cases (N=31) were newly diagnosed, pre-treatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers; further classified as early-onset (diagnosed at 20-49 years (N=12)) or late-onset cancers (diagnosed ≥50 years (N=19)), for secondary exploratory analyses. Cancer-free controls (N=31) were unrelated, and frequency matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analysis (n=175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years and a third were women. While there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Further, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiological investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity.
- 6 May 2026
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (8) , 443-451
Oral microbiota in early- and late-onset tongue cancers: A pilot case-control study
Evidence for the role of oral microbiota in tongue cancers is limited despite early-onset and unexplained etiology. We assessed oral microbiota profiles in saliva among participants with tongue cancers in the oral cavity compared to cancer-free controls. We conducted a case-control study in a tertiary care cancer hospital in Chennai, South India. Cases (N=31) were newly diagnosed, pre-treatment, biopsy-confirmed, early-stage (<4 cm size) tongue cancers; further classified as early-onset (diagnosed at 20-49 years (N=12)) or late-onset cancers (diagnosed ≥50 years (N=19)), for secondary exploratory analyses. Cancer-free controls (N=31) were unrelated, and frequency matched to the cases on age and sex. Bacterial characterization of saliva was performed using 16S rRNA sequencing. Analysis (n=175 genera) included linear regression for α-diversity, constrained analysis of principal coordinates, permutational multivariable analysis of variance for β-diversity, and analysis of compositions of microbiomes with bias correction for taxa abundance. We also examined differences in established bacterial pathogens selected a priori. The median age of participants was 52 years and a third were women. While there was no difference in α-diversity, β-diversity showed distinct clustering of bacterial genera in controls, early-onset, and late-onset cases. In overall and early-onset cases (vs. controls), genera Eikenella and Campylobacter showae were enriched. Further, in early-onset cases (vs. controls), genera Alloprevotella, Comamonas, Aggregatibacter were enriched, Oribacterium was depleted, and W5053 had differentially absent patterns. Beyond the established pathogens, this study offers important leads for future etiological investigations, particularly in exploratory analyses of early-onset tongue cancers in the oral cavity.
- 30 January 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (5) , 3071-3080
Comparative de novo transcriptome analysis and metabolic pathway studies of Citrus paradisi flavedo from naive stage to ripened stage
Grapefruit (Citrus pardisi) is a popular citrus fruit that is a cross between a sweet orange and pummelo. This research article focuses on an in silico approach for comparative analysis of C. paradisi green flavedo (GF) and ethylene treated flavedo (ETF) transcriptome data. Our pathway analysis provides comprehensive information of genes playing significant role in different stages of ripening in fruit. De novo assembly was carried out using six different assemblers namely GS assembler, SeqMan NGEN, Velvet/Oases, CLC, iAssembler and Cortex followed by subsequent meta-assembly, annotation and pathway analysis. We conclude that de novo transcriptome assembly using meta-assembly approach is used to increase assembly quality in comparison to single assembler.
- 30 January 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (5) , 3071-3080
Comparative de novo transcriptome analysis and metabolic pathway studies of Citrus paradisi flavedo from naive stage to ripened stage
Grapefruit (Citrus pardisi) is a popular citrus fruit that is a cross between a sweet orange and pummelo. This research article focuses on an in silico approach for comparative analysis of C. paradisi green flavedo (GF) and ethylene treated flavedo (ETF) transcriptome data. Our pathway analysis provides comprehensive information of genes playing significant role in different stages of ripening in fruit. De novo assembly was carried out using six different assemblers namely GS assembler, SeqMan NGEN, Velvet/Oases, CLC, iAssembler and Cortex followed by subsequent meta-assembly, annotation and pathway analysis. We conclude that de novo transcriptome assembly using meta-assembly approach is used to increase assembly quality in comparison to single assembler.